Key Updates
Renault shares declined 2.13% to $33.54 since the January 8th report, marking the eighth consecutive session of losses and bringing YTD performance to -5.31%. The continued deterioration reflects broader European automotive sector weakness, with the stock down 18.59% over six months. Three new developments emerged: Bank of America identified European automakers including Renault as having 25% rerating potential if regulatory changes improve, the EU reduced its 2035 CO2 target from 100% to 90%, and European car sales showed modest growth with affordable EVs gaining traction. Despite positive regulatory momentum, Renault's technical breakdown accelerates as shares approach critical support levels established in mid-2024.
Current Trend
Renault shares trade at $33.54, down 5.31% YTD and extending losses to eight consecutive sessions. The stock has declined 18.59% over six months, significantly underperforming the broader European automotive sector. The 1-month decline of 9.67% and 5-day decline of 5.79% indicate accelerating downward momentum. Current price action suggests the stock is testing critical support levels, with the recent breakdown from the €35-36 range representing a significant technical deterioration. The persistent selling pressure despite positive regulatory developments indicates fundamental concerns are outweighing potential policy benefits.
Investment Thesis
The investment thesis for Renault centers on three pillars: (1) successful execution of affordable EV strategy with models like the R5 E-Tech and upcoming sub-€20,000 Twingo positioning the company competitively against Chinese manufacturers, (2) potential 25% valuation rerating from current 4-5x earnings multiple if EU regulatory changes improve long-term survival expectations, and (3) market share gains in the mass-market EV segment as budget-conscious consumers shift from premium brands. The thesis assumes Renault can leverage its European manufacturing footprint and brand heritage to defend against Chinese competition while capitalizing on government incentives in key markets like Germany and Spain. Critical to this thesis is maintaining profitability in the affordable EV segment where margins are traditionally compressed.
Thesis Status
The investment thesis shows mixed progress with emerging headwinds. Positive developments include Bank of America's explicit identification of Renault as a beneficiary of EU CO2 policy rollback, with potential for 25% rerating from current depressed valuations (CNBC), and confirmed traction for affordable EVs like the R5 E-Tech gaining market share from premium brands (Bloomberg). However, the 8-session losing streak and 18.59% six-month decline suggest investors remain skeptical about execution risks and margin sustainability. The EU's revised 90% CO2 reduction target provides moderate relief but falls short of eliminating competitive pressures from Chinese manufacturers, who increased European sales 91% in the first nine months of 2025 to capture 5.2% market share (Forbes). The thesis remains intact but requires near-term evidence of improving profitability and sustained market share gains to reverse negative sentiment.
Key Drivers
Regulatory environment: The EU's decision to reduce 2035 CO2 targets from 100% to 90% provides moderate relief for traditional manufacturers, with UBS noting potential benefits for Renault in the small affordable EV segment (Forbes). Bank of America suggests this policy shift could enable a 25% valuation rerating for undervalued European automakers trading at 4-5x earnings (CNBC).
Product momentum: Renault's affordable EV strategy shows traction, with the R5 E-Tech and Citroën ë-C3 driving mass-market manufacturers to gain EV market share from Tesla, BMW, and Mercedes (Bloomberg). The upcoming sub-€20,000 Twingo launch in 2025 positions Renault competitively against Chinese budget offerings. However, the Renault 4 test drive revealed significant underperformance versus manufacturer claims, achieving only 182 miles versus 247 miles claimed range and 2.8mi/kWh versus 4.0mi/kWh efficiency (Forbes).
Competitive dynamics: Chinese manufacturers continue aggressive European expansion, with BYD increasing Italian sales eight-fold to nearly 24,000 units while expanding to over 100 retail outlets (Reuters). European new-car registrations increased 2.4% in November with battery-electric sales surging 37%, though overall demand remains below pre-pandemic levels due to elevated prices and cost-of-living pressures (Bloomberg).
Sector sentiment: Jefferies expects Stellantis and Volkswagen to guide for improved 2026 operations, with Stellantis shares rising 2.4% on positive analyst commentary (WSJ). However, broader sector challenges persist, with Italy's total car sales declining 2.12% in 2025 and Stellantis market share contracting from 23.8% to 21.5% in December alone (Reuters).
Technical Analysis
Renault shares at $33.54 have broken through critical support at the €35 level established in previous reports, with eight consecutive declining sessions indicating strong bearish momentum. The stock trades 18.59% below its six-month high, approaching technical oversold conditions but showing no signs of stabilization. The 5-day decline of 5.79% accelerates the 1-month decline of 9.67%, suggesting capitulation selling. Key support now sits at the $32-33 range representing mid-2024 lows, while resistance has formed at the recently broken €35 level. The persistent downtrend despite positive fundamental catalysts indicates technical damage may require extended consolidation before recovery. Volume patterns and momentum indicators suggest further downside risk unless the stock can establish support above $33 and reclaim the €35 level on increased buying volume.
Bull Case
- Bank of America identifies Renault as having 25% rerating potential from current 4-5x earnings valuation if EU regulatory changes improve long-term survival expectations, representing significant upside from depressed levels (CNBC)
- Affordable EV models including R5 E-Tech and upcoming sub-€20,000 Twingo position Renault to capture market share as mass-market manufacturers gain ground against premium brands like Tesla, BMW, and Mercedes in the growing budget EV segment (Bloomberg)
- EU's revised 90% CO2 reduction target provides moderate benefits for Renault in the small affordable EV segment while eliminating complete ICE ban risk, according to UBS analysis (Forbes)
- European battery-electric vehicle sales surged 37% in November with planned government incentives in Germany and Spain expected to further boost EV adoption, creating favorable market conditions for Renault's product portfolio (Bloomberg)
- Jefferies expects improved 2026 operations guidance from European automakers including Stellantis, suggesting broader sector recovery that could benefit Renault as investor sentiment improves (WSJ)
Bear Case
- Chinese manufacturers increased European sales 91% in first nine months of 2025 to capture 5.2% market share, with BYD expanding to over 100 Italian retail outlets and achieving eight-fold sales growth, intensifying competitive pressure on Renault's core markets (Reuters, Forbes)
- Renault 4 real-world testing revealed significant underperformance with only 182 miles actual range versus 247 miles claimed and 2.8mi/kWh efficiency versus 4.0mi/kWh target, raising concerns about product competitiveness and margin sustainability in the affordable EV segment (Forbes)
- Italy's total car sales declined 2.12% in 2025 with Stellantis market share contracting from 23.8% to 21.5% in December, indicating persistent demand weakness in key European markets despite modest November growth (Reuters)
- Overall European demand remains below pre-pandemic levels due to elevated vehicle prices and cost-of-living pressures affecting consumer purchasing decisions, constraining volume growth potential across the sector (Bloomberg)
- Eight consecutive sessions of losses totaling 18.59% decline over six months demonstrates persistent negative investor sentiment despite positive regulatory developments, suggesting fundamental concerns about profitability and execution risks outweigh policy benefits (CNBC)